In the case of ACOX1, the p. Asp237Ser variant has been associated with increased enzyme activity and elevated levels of reactive oxygen species (ROS), contributing to axonal loss and neurodegeneration, as seen in conditions like Mitchell syndrome (MITCH). This evidence concerns the gene ACOX1 and Down syndrome.